SII official had put in an application to the DCGI on January 6 stating the firm, in collaboration with Novavax, is working on the development of a vaccine against Omicron.
Adar Poonawalla, CEO of Serum Institute of India (SII), on Thursday suggested that the government should reduce the gap between the second and the third dose to six months to meet global standards.
Conditional market authorisation was granted on Thursday by the Drugs Controller General of India (DCGI) to COVID-19 vaccines Covishield and Covaxin for use in adults.However, this doesn’t mean the two COVID-19 vaccines will be available at shops soon though people would be able to buy them from hospitals and clinics, sources have said. Key details […]